Number of Shares
98,000.00
Current Holdings Value*
$63.22 Mil
% of Portfolio
4.65%
Total Estimate Gain
$112.69 Mil
% of Total Estimate Gain
168.08%

Fidelity Advisor Biotechnology Fund's argenx SE Holding Summary

As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 98,000.00 shares of argenx SE(ARGX), totaling $63.22 Mil. This investment constitutes 4.65% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.16% of the outstanding argenx SE(ARGX) stock.

The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 5 purchases of ARGX, at an average price of $166.09, for a total of 403,700.00 shares. In addition, there have been 9 sales at an average price of $406.94 for 305,700.00 shares. Based on historical transaction data and ARGX's current price of $564.71, Fidelity Advisor Biotechnology Fund's estimated gain on his ARGX holdings is $112.69 Mil, reflecting a 168.08% gain to date.

Fidelity Advisor Biotechnology Fund ARGX ($564.71) Holding Chart

Fidelity Advisor Biotechnology Fund ARGX ($564.71) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1